<<
macrobiotic diet
palliative care
macrocytosis
Down syndrome
macrogol
macrolides
clinical pharmacology
macules
acne
macule (definition)
magnesium
drug-induced arrhythmias
formulations
magnesium antacid
magnesium aspartate
magnesium chloride
magnesium hydroxide
magnesium sulfate
magnesium supplements
hypermagnesaemia
causes
management
hypomagnesaemia
causes
management
palliative care (table)
magnesium antacid
magnesium aspartate
magnesium chloride
magnesium hydroxide
magnesium replacment
drug-induced arrhythmias
magnesium salts
magnesium sulfate
magnesium supplements
magnesium+aluminium hydroxide
magnetic field therapy
palliative care
magnetic resonance imaging
epilepsy
headache
cough exertional or sexual
exertional or sexual)
headache (cough
exertional or sexual)
lumbosacral plexitis
multiple sclerosis
stroke
children
maintenance intravenous fluids (table)
major depressive disorder
adjustment disorder with depressed and/or anxious mood
assessment
assessment considerations (box)
bipolar depression
changing antidepressants
antidepressant-free intervals (table)
children
diagnosis
nonpharmacological treatment
pharmacological treatment
other antidepressants
selective serotonin reuptake inhibitors
suicidal ideation and behaviour
dysthymic disorder
electroconvulsive therapy
major depression
perinatal depression
recurrent depression
suicidal patients
risk factors (box)
suicide risk assessment (box)
treatment
nonpharmacological
pharmacological
antidepressant discontinuation
concurrent anxiolytic or hypnotic
failure to respond
first-line therapy
general considerations
second-line therapy
principles
major trauma
abdominal injuries
chest injuries
head injuries
Makaton vocabulary
Prader-Willi syndrome: biopsychosocial issues
Unaided augmentative and alternative communication systems: developmental disability
malabsorption
bacterial overgrowth
chronic pancreatitis
coeliac disease
Crohn's disease
cystic fibrosis
short bowel syndrome
vitamin deficiency
malaria
G6PD deficiency
prophylaxis
stand-by treatment
treatment
Plasmodium falciparum
severe
uncomplicated
Plasmodium malariae
Plasmodium ovale
Plasmodium vivax
vector avoidance
Malassezia yeasts
folliculitis
pityriasis versicolor
malathion
maldison
male contraception
hormonal
androgen
androgen combination
nonhormonal
condoms
device-free methods
vasectomy
male infertility
antirheumatic drugs
empirical therapy
gonadotrophin therapy
sperm autoimmunity
male sexual dysfunction
ejaculatory disorders
ejaculatory failure
premature ejaculation
erectile dysfunction
apomorphine
intracavernosal therapy
management algorithm (figure)
penile implants
phosphodiesterase type 5 inhibitors
priapism
transurethral therapy
vacuum devices
premature ejaculation
priapism
malignancy (see also cancer)
childhood (palliative care)
hypercalcaemia of
malignant middle cerebral artery infarction
malignant multiple sclerosis
malignant otitis externa
malingering
Mallampati score (figure)
procedural sedation record
MALT lymphoma
H. pylori and gastric cancer
Indications to test for and treat H. pylori infection (Table 6.4)
management plan
asthma
mandibular splinting
obstructive sleep apnoea
mania (acute)
developmental disability
treatment
behavioural disturbance (oral)
behavioural disturbance (parenteral)
continuation
failure to respond
pathologically elevated mood
principles
manic depressive illness
acute treatment
behavioural disturbance (oral)
behavioural disturbance (parenteral)
continuation
failure to respond
pathologically elevated mood
principles for acute mania
bipolar depression
treatment
failure to respond
pharmacological
principles
children (juvenile)
Bipolar disorder: general information
Juvenile bipolar disorder
dysphoric mania
general information
mixed episodes
prophylactic treatment
key interventions
broad treatment program
co-morbidity management
family/carer involvement
physical health management
pharmacological
psychological
rapid cycling
manipulation
neck pain
acute
chronic
palliative care
mannitol
Mantoux test
tuberculosis latent infection
manual therapies
MAOIs
adverse effects
frequency (table)
breastfeeding
changing antidepressants
antidepressant-free intervals (table)
clinical pharmacology
dietary guidelines (table)
interactions
pharmacokinetics properties (table)
pregnancy
Marburg virus
marijuana
therapeutic use
spasticity (multiple sclerosis)
spasticity (palliative care)
marine envenoming
clinical features of stings or injuries (table)
first aid and treatment
geographical distribution in Australia (table)
marine poisoning
mask ventilation
masquerades (developmental disability)
massage
low back pain
palliative care
Complementary and alternative medicines
Domicillary palliative care: what is available to meet the needs?
general pain
muscle pain
post-traumatic headache
tension headache
massive transfusion
mastalgia
cyclical pain
noncyclical pain
mastitis
mastoiditis
otitis media
masturbation (developmental disability)
anal
excessive
privacy
maternal serum screening
developmental disability
mauve stinger (table)
McDonald criteria
definition
diagnosis of multiple sclerosis
McMurray's test
MDIs (metered dose inhalers)
breath-actuated
common errors in use
products available
propellants
technique
MDMA (ecstasy)
general information
overdose and toxicity
poisoning
amphetamines
serotonin toxicity (table)
mebendazole
mebeverine
mechanical syndromes
spinal pain
MEDI-Spacers (spacing devices)
medial branch blocks
medial epicondylitis
characteristics
management
medial tibial stress syndrome
medical emergencies
dental surgery
drugs and equipment required
types
allergies
anaphylactic and anaphylactoid reactions
cardiovascular
endocrine
neurological
respiratory
dermatological
dermatitis (severe)
drug eruptions
eczema herpeticum
erythema multiforme
erythroderma
generalised pustular psoriasis
immunobullous disorders
meningococcal septicaemia
staphylococcal scalded skin syndrome
Stevens-Johnson syndrome
toxic epidermal necrolysis
vasculitis
endocrine
clinical presentations
palliative care
airways obstruction (acute)
haemorrhage
spinal cord compression
superior vena cava obstruction
medication-induced
diarrhoea
headache
medication-induced headache
medication-overuse headache
medication review
developmental disability
adolescents
aged care
epilepsy
preventive health care
Health screening in people with developmental disability
Preventive health care and health promotion in people with developmental disability: medication review
medication review (developmental disability)
preventive health care
medications
ceasing in terminal phase
Addison's disease
diabetes
hypercholesterolaemia
hypertension
psychological effects
Burden of disease in patients receiving palliative care
Intercurrent illnesses and palliative care
thyroid disease
children
drugs (and doses) commonly used in paediatric palliative care (table)
dental management of patients taking
impaired swallowing
practical issues related to domiciliary care
meditation
pain management
medium-chain triglycerides
medroxyprogesterone acetate
mefenamic acid
Mefenamic acid index page
Nonsteroidal anti-inflammatory drugs (NSAIDs) index page
mefloquine
megaloblastic anaemia
megestrol acetate
meibomian abscess
melaena
melaleuca oil
melanocytic naevi
Birthmarks
Melanocytic naevi (moles)
giant
pigmented birthmarks
melanoma
diagnosis (box)
investigation and follow-up
management
excision margins (box)
nail apparatus
palliative care
prognosis
survival rates (box)
types
acral lentiginous
desmoplastic
lentigo maligna (Hutchinsons melanotic freckle)
nodular
superficial spreading
warning signs (box)
melasma
melatonin
melioidosis
biological warfare
systemic infection
meloxicam
memantine
men’s health
developmental disability
Health screening in people with developmental disability
Men’s health (developmental disability)
androgen deficiency
diagnosis
symptoms
treatment
cryptorchidism
testicular surveillance
delayed puberty
ejaculatory failure
erectile dysfunction
inguinal hernia
prostate cancer
screening
symptoms
menarche
developmental disability
Down syndrome: secondary school (12 to 18 years)
Women’s health (developmental disability): menarche and onset of puberty
Meniere's disease
recurrent vertigo
meningitis
corticosteroids
directed therapy
cryptococcal
Haemophilus influenzae type b
Listeria monocytogenes
Neisseria meningitidis (meningococcal)
Streptococcus agalactiae
Streptococcus pneumoniae
empirical therapy
health care-associated
home-based therapy
immediate and early hospital management
management algorithm
neonates and infants
prophylaxis
Chemoprophylaxis for meningitis
Haemophilus influenzae type b
Haemophilus influenzae type b
Neisseria meningitidis (meningococcus)
meningococcal meningitis
meningococcal sepsis
meningococcal septicaemia
meningococcus
conjunctivitis
meningitis
Meningitis: introduction
Neisseria meningitidis (meningococcal meningitis)
severe sepsis
meniscal cysts
menopause
developmental disability
Down syndrome: adulthood
Women’s health (developmental disability): menopause
HRT
benefits and risks
continuous combined
contraindications
cyclical combined
duration
implant therapy
initiating
key points (Box)
long-term use
cancer
cardiovascular disease
cognitive function
fractures
thromboembolic disease
monitoring therapy
older women
osteoporosis
postmenopausal bleeding
progestin intolerance
testosterone therapy
tibolone
topical oestrogen therapy
transdermal oestrogen therapy
unopposed oestrogen therapy
menopause symptoms
menorrhagia
anovulatory
COCP
cyclical progestins
developmental disability
dysfunctional uterine bleeding
antiprostaglandins
COCP
danazol
GRH analogues
progestins
tranexamic acid
treatment (table)
investigations
secondary
menstrual disorders
breakthrough bleeding
developmental disability
management
Down syndrome: secondary school (12 to 18 years)
Management of an adolescent with developmental disability: checklist of issues to be addressed in adolescence (Table 11.8)
Symptoms more common in people with developmental disability: inability to cope with menstruation
Women’s health (developmental disability): menstrual management
problems
suppression
dysmenorrhoea
menorrhagia
migraine
normal menstrual cycle
oligomenorrhoea
Oligomenorrhoea
Secondary amenorrhoea
physiology of menstruation (figure)
menstruation
normal cycle
physiology (figure)
mental health
developmental disability
adolescents
Management of an adolescent with developmental disability: checklist of issues to be addressed in adolescence (Table 11.8)
Management of an adolescent with developmental disability: medical issues
adults
cerebral palsy
Down syndrome
menthol
meperidine
mepivacaine
mercaptopurine
mercury poisoning (table)
meropenem
mesalazine
mesna
mesothelioma
mestranol
metabolic adverse effects
antipsychotic drugs
Antipsychotic drugs: adverse effects
Treatment of schizophrenia: management of antipsychotic adverse effects
metabolic storage disorder
palliative care
metabolic syndrome
metaraminol
metastases
bone (palliative care)
skin (palliative care)
metastatic deposits
lung cancer
metatarsalgia
metered dose inhalers (MDI)
breath-actuated
common errors in use
products available
propellants
technique
metformin
methadone
methaemoglobinaemia
articaine
causative agents
clinical effects (table)
dapsone
prilocaine
treatment
methamphetamine
abuse
breastfeeding
overdose and toxicity
pregnancy
methanol
poisoning
immediate antidote treatment
paediatric poisoning (table)
methicillin
clinical pharmacology
methicillin-resistant Staphylococcus aureus
community-associated
boils and carbuncles
endocarditis
severe sepsis
endocarditis
osteomyelitis
prostheses-related
peritonitis complicating CAPD
recurrent skin infection
severe sepsis
febrile neutropenia
surgical prophylaxis
endoscopic procedures
vancomycin monitoring
VISA
surgical prophylaxis
wound infections (postoperative)
methimazole
methotrexate
methoxsalen
methoxyflurane
methyl salicylate
methyldopa
methylene blue
methylenedioxymethamphetamine (ecstasy)
general information
overdose and toxicity
methylphenidate
methylprednisolone
methylprednisolone aceponate
methysergide
metoclopramide
metoprolol
metronidazole
metyrapone
mexiletine
mianserin
miconazole
microscopic polyangiitis
diagnosis
features
investigations
prognosis
treatment
Microscopic polyangiitis
Treatment regimens for systemic vasculitis (polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis)
induction of remission
maintenance
microsporidia
microvascular decompression
hemifacial spasm
trigeminal neuralgia
midazolam
midodrine
migraine
acute attack
first-line treatment
general considerations
precautions with treatment
second-line treatment
treatment of nausea and vomiting
aura without headache
breastfeeding
children
classical
common
facial
hormone replacement therapy
lactation
menstrual
oral contraceptives
persistent
pregnancy
prophylaxis
nonpharmacological
pharmacological
resistant
stroke risk
vertigo
Migrainous vertigo
Recurrent vertigo: introduction
with aura
without aura
migrainous vertigo
milestones developmental (developmental disability)
milia
definition
miliaria
miliary tuberculosis
milk and milk products
calcium content
lactose content
Miller Fisher variant
milrinone
mineral deficiency
palliative care
vitamin and mineral deficiencies (table)
mineralocorticoids
Addison's disease
clinical pharmacology
hypopituitarism
Mini-mental State Examination (MMSE)
developmental disability
minimum volume resuscitation
ectopic pregnancy
minipill
minocycline
minoxidil
mirtazapine
miscarriage
abortifacients
complementary and alternative medicines
systemic lupus erythematosus
misoprostol
missed pill instructions
mitotane
mitoxantrone
mitozantrone
mixed connective disease
features
prognosis
treatment
mixed insulin regimen
MMSE (Mini-mental State Examination)
developmental disability
mobilisation
neck pain
acute
chronic
sprains and strains
mobility (developmental disability)
Aged care in people with developmental disability: osteoporosis, falls and fractures
Constipation in adults with developmental disability: introduction
Management of an adolescent with developmental disability: checklist of issues to be addressed in adolescence (Table 11.8)
Mobiluncus species
bacterial vaginosis
moclobemide
modafinil
models of disability
modified-release preparations
analgesic drugs
modulation of pain
Mohs' surgery
basal cell carcinoma
intraepidermal carcinoma (Bowen's disease)
moisturisers
prescribing
properties
types (table)
molluscum contagiosum
mometasone
monitoring
antiepileptic drugs
biochemical
haematological
plasma concentrations
toxicity
biochemical parameters
antipsychotic drugs
carbamazepine
clozapine
lithium
mianserin
sodium valproate
drug blood levels
aminoglycosides
antiepileptic drugs
beta lactams
carbamazepine
Acute mania: primary treatment of pathologically elevated mood
Prophylaxis for bipolar disorder: pharmacological treatment
clozapine
endocarditis
flucytosine
itraconazole
lamotrigine
lithium
Acute mania: primary treatment of pathologically elevated mood
Prophylaxis for bipolar disorder: pharmacological treatment
phenytoin
psychotropic drugs
sodium valproate
Acute mania: primary treatment of pathologically elevated mood
Prophylaxis for bipolar disorder: pharmacological treatment
teicoplanin
vancomycin
monoamine oxidase inhibitors irreversible nonselective (see also individual drugs)
adverse effects
frequency (table)
breastfeeding
changing antidepressants
antidepressant-free intervals (table)
clinical pharmacology
dietary guidelines (table)
interactions
pharmacokinetics properties (table)
poisoning
pregnancy
monoarthritis
blood tests
causes
diagnostic clues (box)
joint aspiration
radiological examination
treatment
when to refer
monobactams
clinical pharmacology
mononucleosis (infectious)
monosodium urate deposition disease
asymptomatic hyperuricaemia
characteristics
chronic tophaceous gout
clinical presentation
acute
asymptomatic hyperuricaemia
chronic
subacute
diagnostic workup
drugs affecting
hyperuricaemia prevalence
kidney
chronic urate nephropathy
nephrolithiasis
management
acute
chronic
general considerations
intercritical
pathogenesis
uric acid metabolism
montelukast sodium
mood disorders
bipolar disorder
depression
Depression
Depression: introduction
fragile X syndrome
grief
mixed mood episodes (developmental disability)
mood disturbances
palliative care
depression
euphoria and elation
mood stabilisers (see also individual drugs)
bipolar disorder
acute treatment
developmental disability
prophylaxis
drugs for bipolar disorder
antiepileptics
lithium
fragile X syndrome
Moraxella catarrhalis
COPD (acute exacerbation)
otitis media
sinusitis
morphine
morphoea
generalised
linear
morphology of skin lesions
definitions
Features associated with skin lesions (Table 4.2)
Types of skin lesions (Table 4.1)
localisation of skin disease
patterns of lesions
Morton's neuroma
motility stimulants
motion-induced vertigo
benign paroxysmal positional
vestibular lesion (uncompensated)
motion sickness
prophylaxis
treatment
motor dysfunction
palliative care
Parkinson's disease
motor neurone disease
palliative care
moulds
risk factors for asthma
mouth care
developmental disability
Commonly unrecognised or untreated conditions in adults with developmental disability
Health screening in people with developmental disability
Oral health in people with developmental disability
cerebral palsy
Cerebral palsy: dental health
Cerebral palsy: management of associated health problems
dental caries
dental erosion
dental malocclusion
Down syndrome
dysphagia
Dysphagia in people with developmental disability: management
Oral health in people with developmental disability
periodontal disease
Prader-Willi syndrome
saliva control
palliative care
mouthwashes (see also individual agents)
use of alcohol in
movement disorders
chorea
drug-induced
dystonias
drug-induced
focal
generalised
hemifacial spasm
hyperkinetic
hypokinetic
myoclonus
palliative care
Parkinson's disease
Parkinson plus disorders
corticobasal ganglionic degeneration
multiple system atrophy
progressive supranuclear palsy
prevalence (table)
symptoms
tardive syndromes
tics
tremor
essential
isolated
orthostatic
task-specific
moxifloxacin
moxonidine
MRI (magnetic resonance imaging)
epilepsy
headache (cough
exertional or sexual)
lumbosacral plexitis
multiple sclerosis
stroke
children
MRSA
community-associated
boils and carbuncles
endocarditis
severe sepsis
endocarditis
osteomyelitis
prostheses-related
peritonitis complicating CAPD
recurrent skin infection
severe sepsis
febrile neutropenia
surgical prophylaxis
endoscopic procedures
vancomycin monitoring
VISA
surgical prophylaxis
wound infections (postoperative)
mucocutaneous herpes simplex
mucolytics
chronic obstructive pulmonary disease
clinical pharmacology
cystic fibrosis
mucopolysaccaride storage disorders (developmental disability)
mucosa-associated lymphoid tissue lymphoma
H. pylori and gastric cancer
Indications to test for and treat H. pylori infection (Table 6.4)
mucosal disease
angular cheilitis
candidosis
discolourations
erythema multiforme
fungal infections
geographic tongue
hairy tongue
lichen planus
mucositis
mucous membrane pemphigoid
oral hairy leukoplakia
pemphigus vulgaris
ulcers
mucositis
AIDS
management
palliative care
mucous membrane pemphigoid
photo
mulga snake bite
antivenom treatment
coagulopathy type (table)
envenoming effects (table)
multidimensional approach to chronic pain
multidisciplinary team
chronic obstructive pulmonary disease
multifocal motor neuropathy with conduction block
multimodal analgesia
definition
perioperative pain
multimodal communication (developmental disability)
multiple chemical sensitivity
multiple injuries
pain management
multiple sclerosis
anaesthetics
breastfeeding
Devic's disease
diagnosis
diet
Multiple sclerosis: general advice
Multiple sclerosis: therapy directed at symptoms
genetic risk
hormone replacement therapy
immunisation
monitoring
oral contraceptives
palliative care
pregnancy
relapses
acute
mild
moderate
severe
smoking
substance abuse
support groups
surgery
symptoms
Multiple sclerosis: introduction
Symptoms of multiple sclerosis (Box 7.3)
bladder
bowel
fatigue
neurological
psychiatric
sexual difficulties
spasticity
tremor
trigeminal neuralgia
therapy
immunomodulators
immunosuppressants
monitoring
nonresponders
underlying disease
travel
trigeminal neuralgia
types
Multiple sclerosis: introduction
Types of multiple sclerosis (Table 7.12)
benign
malignant
primary progressive
relapsing-remitting
relapsing progressive
secondary progressive
table
multiple system atrophy
prevalence
treatment
multisystem failure
palliative care
multitrauma patients
assessment (box)
pain management
mupirocin
muromonab-CD3
prevention of lung rejection
muscle cramps
muscle diseases
acquired myopathies
dermatomyositis
inclusion body myositis
muscular dystrophies
polymyositis
muscle paralysis
neuromuscular blocking agents
rapid sequence induction
therapeutic hypothermia
muscle relaxants
muscle relaxation
pain management
muscle spasm
nonsurgical postoperative pain
muscular dystrophy
palliative care
musculoskeletal disorders
dental issues in patients with
developmental disability
cerebral palsy
Cerebral palsy: management of associated health problems
Cerebral palsy: musculoskeletal effects
palliative care
bone metastases
cramps and spasms
myoclonus
myopathies and myasthenias
restless legs syndrome
rheumatology guidelines
mushrooms
poisoning
myasthenia
palliative care
myasthenia gravis
diagnosis
ocular
thymectomy
treatment
mycobacterial infections
M. abscessus
M. avium complex
cervical lymphadenitis
disseminated
Disseminated Mycobacterium avium complex (MAC)
Mycobacterium avium complex (MAC): introduction
pulmonary
Mycobacterium avium complex (MAC): introduction
Pulmonary Mycobacterium avium complex (MAC)
M. chelonae
M. fortuitum
M. kansasii
M. leprae
M. marinum
M. tuberculosis
M. ulcerans
Mycobacterium abscessus
Mycobacterium avium complex (MAC)
cervical lymphadenitis
disseminated
opportunistic infection (HIV)
pulmonary
Mycobacterium avium complex (MAC): introduction
Pulmonary Mycobacterium avium complex (MAC)
classification
treatment
daily regimen
three times weekly regimen
Mycobacterium chelonae
Mycobacterium fortuitum
Mycobacterium kansasii
Mycobacterium leprae
Mycobacterium marinum
Mycobacterium tuberculosis
cervical lymphadenitis
opportunistic infection (HIV)
respiratory pathogens associated with immunodeficiency (table)
tuberculosis
Mycobacterium ulcerans
mycophenolate mofetil
Mycoplasma species
cough (paediatric)
M. genitalium
pelvic inflammatory disease
urethritis
M. hominis
severe sepsis
vaginosis
pneumonia
Community-acquired pneumonia in adults: introduction
Community-acquired pneumonia in adults: risk classes I and II
Specific therapy for other pathogens causing bacterial pneumonia (Table 2.16)
children
myectomy
myeloma
respiratory pathogens
myocardial infarction
6-month risk of death or MI with ACS-like chest pain (table)
complications following MI
arrhythmias
cardiogenic shock
left ventricular failure
pericarditis
persistent or recurrent pain
right ventricular infarction
dental treatment issues in patients with
emergency
management (box)
non-ST elevation acute coronary syndromes (NSTEACS)
features (box)
features associated high-
intermediate-
& low-risk NSTEACS (box)
high-risk patients
intermediate-risk patients
low-risk patients
ST elevation infarction (STEMI)
complications following MI
immediate and early hospital management
reperfusion therapy
fibrinolytic therapy
adjuvant antithrombin therapy
contraindications to (box)
haemorrhage and fibrinolytic therapy
indications for reperfusion therapy (box)
percutaneous coronary intervention (PCI)
subsequent management of STEMI
ACE inhibitors
dosing regimens for (table)
aldosterone antagonists
angiotensin II receptor blockers
anticoagulants
antiplatelet therapy
beta blockers
calcium channel blockers
statins
myocardial ischaemia
initial emergency management (flowchart)
myoclonic seizures
definition
myoclonus
definition
movement disorders
palliative care
myopathies
acquired
palliative care
myotonia
myotoxicity
myxoedema coma
myxoid pseudocyst
>>